A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31)
NCT01049282
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
BIOLOGICAL:
Antigen (Ag85B-ESAT-6)
BIOLOGICAL:
Antigen (Ag85B-ESAT-6) with adjuvant (IC31)
Sponsor
Statens Serum Institut